» Articles » PMID: 16227286

Selection of Muscle-binding Peptides from Context-specific Peptide-presenting Phage Libraries for Adenoviral Vector Targeting

Overview
Journal J Virol
Date 2005 Oct 18
PMID 16227286
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Production of cell-targeting vectors in part involves the addition of new targeting ligands to the vector to mediate binding to the cells of interest. For viral vectors, the ideal approach is to genetically engineer new ligands into the capsid proteins of the virus to generate a single agent to mediate therapy. Although this is ideal, this insertion of an exogenous ligand from one structural context into the differing structural context of a capsid protein can ablate the function of the ligand or disrupt viral assembly and function. To address this context problem for adenoviral vectors, we have engineered a "context-specific" peptide-presenting phage library. We have displayed a 12-amino-acid (12-mer) random peptide library between the H and I sheets of the fiber protein of adenovirus type 5 on the pIII protein of fd bacteriophage. This library was used for peptide selection against C2C12 mouse skeletal muscle cells. Five rounds of selection combined with four rounds of clearing on nontarget cells selected one primary peptide designated 12.51, which bound target C2C12 cells approximately 100-fold better than the positive control RGD peptide. Translation of 12.51 back into the fiber protein produced a ligand-modified adenoviral vector that mediated 14-fold-better transduction of target C2C12 cells. These data suggest context-specific peptide-presenting libraries may allow selection of compatible peptide ligands for functional translation into viral vectors for retargeting.

Citing Articles

Targeting Drug Delivery System to Skeletal Muscles: A Comprehensive Review of Different Approaches.

Li X, Xu J, Yao S, Zhang N, Zhang B, Zhang Z J Cachexia Sarcopenia Muscle. 2025; 16(1):e13691.

PMID: 39910928 PMC: 11799587. DOI: 10.1002/jcsm.13691.


Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles to cystic fibrosis lung epithelia.

Soto M, Lewis M, Leal J, Pan Y, Mohanty R, Veyssi A Mol Ther Nucleic Acids. 2024; 35(4):102375.

PMID: 39640013 PMC: 11617931. DOI: 10.1016/j.omtn.2024.102375.


Strategies for Modifying Adenoviral Vectors for Gene Therapy.

Muravyeva A, Smirnikhina S Int J Mol Sci. 2024; 25(22).

PMID: 39596526 PMC: 11595218. DOI: 10.3390/ijms252212461.


Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity.

Hajeri P, Sharma N, Yamamoto M Cancers (Basel). 2020; 12(6).

PMID: 32526919 PMC: 7352392. DOI: 10.3390/cancers12061504.


Improving Molecular Therapy in the Kidney.

Rubin J, Barry M Mol Diagn Ther. 2020; 24(4):375-396.

PMID: 32323260 PMC: 7367759. DOI: 10.1007/s40291-020-00467-6.


References
1.
Romanczuk H, Galer C, Zabner J, Barsomian G, Wadsworth S, ORiordan C . Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Hum Gene Ther. 1999; 10(16):2615-26. DOI: 10.1089/10430349950016654. View

2.
Bouri K, Feero W, Myerburg M, Wickham T, Kovesdi I, Hoffman E . Polylysine modification of adenoviral fiber protein enhances muscle cell transduction. Hum Gene Ther. 1999; 10(10):1633-40. DOI: 10.1089/10430349950017635. View

3.
White S, Nicklin S, Sawamura T, Baker A . Identification of peptides that target the endothelial cell-specific LOX-1 receptor. Hypertension. 2001; 37(2 Pt 2):449-55. DOI: 10.1161/01.hyp.37.2.449. View

4.
Nalbantoglu J, Larochelle N, Wolf E, Karpati G, Lochmuller H, Holland P . Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle. J Virol. 2001; 75(9):4276-82. PMC: 114173. DOI: 10.1128/JVI.75.9.4276-4282.2001. View

5.
Cao B, Pruchnic R, Ikezawa M, Xiao X, Li J, Wickham T . The role of receptors in the maturation-dependent adenoviral transduction of myofibers. Gene Ther. 2001; 8(8):627-37. DOI: 10.1038/sj.gt.3301425. View